Search

Your search keyword '"Stossi, Fabio"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Stossi, Fabio" Remove constraint Author: "Stossi, Fabio" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
31 results on '"Stossi, Fabio"'

Search Results

7. Supplementary Data SD1 from Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 Stabilization and Chromatin Condensation

15. Supplementary Data SD1 from Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 Stabilization and Chromatin Condensation

19. Abstract P6-11-15: Lipid accumulation in residual triple negative breast cancer cells surviving chemotherapy treatment

20. Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 Stabilization and Chromatin Condensation

21. Abstract 6355: A characterisation of direct and indirect transcription factor inhibition to target brachyury in chordoma

22. Abstract LB517A: The role of EGFR in resistance to tucatinib and its therapeutic implications

23. Abstract P4-01-01: Resistance to next generation tyrosine kinase inhibitors (TKIs) in HER2-positive breast cancer (BC): Role of HER and PIK3CA mutations and development of new treatment strategies and study models

24. Abstract PD8-06: Acquired resistance to tucatinib is associated with EGFR amplification in HER2+ breast cancer (BC) models and can be overcome by a more complete blockade of HER receptor layer

25. Abstract 1077: Acquired neratinib resistance is associated with acquisition of HER2 and PIK3CA mutations and can be overcome using potent drug combinations in HER2-positive breast cancer models

26. Abstract PD3-09: HER2 L755S mutation is acquired upon resistance to lapatinib and neratinib and confers cross-resistance to tucatinib and trastuzumab in HER2-positive breast cancer cell models

27. Abstract 1911: HER2 L755S mutation is associated with acquired resistance to lapatinib and neratinib, and confers cross-resistance to tucatinib in HER2-positive breast cancer models

30. Abstract 4869: Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects

31. Selective Estrogen Receptor Modulators

Catalog

Books, media, physical & digital resources